ClinicalTrials.Veeva

Menu

The Microbiology of Caries Resistance

University of Florida logo

University of Florida

Status and phase

Completed
Phase 2

Conditions

Dental Caries

Treatments

Other: Caries Free - Placebo
Other: Caries Active
Other: Caries Free
Other: Caries Active - Placebo

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02130206
665-2008
A-2013-197-OC (Other Identifier)

Details and patient eligibility

About

The purpose of this research study is to investigate the bacterial composition of plaque and saliva located in the mouth and associate that with risk factors that cause cavities.

Full description

Pre-Screening - If the subject chooses to be pre-screened for this study they will be asked to fill out a study registration form and an oral habits/medical history form. They will be asked to sign an Informed Consent. The subject will then have their teeth and gums examined. At this visit, the investigator will assess whether or not the subject is a good candidate for the study. During the phone interview each subject was asked not to brush or floss their teeth and not to eat or drink anything other than water for 8 hours prior to the pre-screening visit (Visit 0). If the subject was compliant with these requests, oral samples will be collected at this pre-screening visit and will now be considered Visit 1 (Baseline). If not, they will be asked to return to the clinic for another visit and asked not to brush or floss their teeth and not to eat or drink anything other than water 8 hours prior to that appointment. This visit will then be consider Visit 1 (Baseline).

Visit 1 (Baseline) - The subject will have their medical and dental history reviewed. They will have their teeth and gums examined. Saliva and plaque will be collected. Each subject will be given a toothbrush and toothpaste and instructed to not use any other dental products. This will be considered the "washout" period.

Visit 2 - The subject will be asked to return the unused toothpaste. Their medical and dental history will be reviewed and they will have their teeth examined. Saliva and plaque will be collected at this visit. The subjects will then be randomly assigned (by chance, like the flip of a coin) to the group that will use a marketed fluoride-containing toothpaste or to the group that will use a marketed arginine containing toothpaste. The subject will also be instructed not to brush or floss their teeth or eat or drink anything other than water for 8 hours prior to your next appointment.

Visits 3, 4, and 5 - Subjects will not be allowed to brush or floss their teeth or eat or drink anything other than water 8 hours prior to these visits. Saliva and plaque will be collected. On the 5th visit subjects will be asked to return the unused toothpaste tube. At this time participation in this research study will end and they will be instructed to return to their regular oral hygiene regiments.

Enrollment

79 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Twenty natural teeth excluding third molars
  • No contraindications to dental treatment
  • Caries Free
  • Caries Active (at least two active sites)

Exclusion criteria

  • Less that twenty teeth
  • Any systemic disease that can cause xerostomia
  • Taking medications that cause xerostomia
  • Antibiotics last three months
  • Advanced Periodontal Disease
  • Removable or fixed dental appliances
  • Bleeding disorders or taking anticoagulant medications
  • Immune compromised individuals
  • Participating in another research study
  • Used flavored products such as mint flavored candies and chewing gum one week prior to or during the study
  • Uses tobacco products
  • Unwilling or unable to provide Informed Consent and follow collection instructions

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

79 participants in 4 patient groups, including a placebo group

Caries Free
Active Comparator group
Description:
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.
Treatment:
Other: Caries Free
Caries Free - Placebo
Placebo Comparator group
Description:
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.
Treatment:
Other: Caries Free - Placebo
Caries Active
Active Comparator group
Description:
Gums will be examined. On some visits Saliva and plaque will be collected. Toothpaste assigned will include DenClude 1.5% Arginine.
Treatment:
Other: Caries Active
Caries Active - Placebo
Placebo Comparator group
Description:
Gums will be examined. On some visits Saliva and plaque will be collected. Marketed Toothpaste will be assigned.
Treatment:
Other: Caries Active - Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems